Back to search

Article

Human iPSC modeling reveals mutation-specific responses to gene therapy in Best disease

2019-10-08

Abstract excerpt

Dominantly inherited disorders are not typically considered therapeutic candidates for gene augmentation. Here, we utilized patient-specific induced pluripotent stem cell-derived retinal pigment epithelium (iPSC-RPE) to test the potential of gene augmentation to treat Best disease, a dominant macular dystrophy caused by over 200 missense mutations in BEST1 . Gene augmentation in iPSC-RPE fully restored BEST1 calc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a98e2234-6180-582d-9f40-fc3f682a1e8e
DOI
10.1101/796581
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Human iPSC modeling reveals mutation-specific responses to gene therapy in Best diseaseDOI 10.1101/796581
Select a neighboring publication to make it the new centre.